Abstract:Prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) is a risk factor for the occurrence of congenital heart diseases (CHDs). Genetic susceptibility to PAHs metabolism may modify the exposure–risk relationship. The role of uridine diphosphoglucuronosyl transferase 1A1 ( UGT1A1 ) genetic polymorphisms for modulating the impacts of prenatal PAHs exposure on the risk of CHDs remains to be discovered. The aim of this study was to investigate whether maternal UGT1A1 genetic polymorphisms are associated with fetal susceptibility to CHDs and to assess whether the risk is modified by maternal PAHs exposure. Maternal urinary biomarker of PAHs exposure was determined in 357 pregnant women with CHDs fetuses and 270 controls (pregnant women carrying fetuses without major congenital malformations). Urinary 1-hydroxypyrene-glucuronide (1-OHPG) concentration, a sensitive biomarker for PAHs exposure, was measured using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry. Maternal single nucleotide polymorphisms (SNPs) in UGT1A1 , including rs3755319, rs887829, rs4148323, rs6742078, and rs6717546, were genotyped using an improved multiplex ligation detection reaction (iMLDR) technique. Unconditional logistic regression was performed to determine the impacts of UGT1A1 polymorphisms on the risks of CHDs and their subtypes. Generalized multifactor dimensionality reduction (GMDR) was used to analyze the gene–gene and gene–PAHs exposure interactions. None of the selected UGT1A1 polymorphisms was independently associated with the risk of CHDs. The interaction between SNP rs4148323 and PAHs exposure was observed to be associated with CHDs ( p < .05). Pregnant women with high-level PAHs exposure and rs4148323 had an increased risk of carrying CHDs fetuses (GA-AA vs. GG: aOR = 2.00, 95% CI = 1.06–3.79). Moreover, the joint effect of rs4148323 and PAHs exposure was found to be significantly associated with risks of septal defects, conotruncal heart defects, and right-sided obstructive malformations. Maternal genetic variations of UGT1A1 rs4148323 may modify the association between prenatal PAHs exposure and CHDs risk. This finding needs to be further confirmed in a larger-scale study.

[Research Progress of the Gene Polymorphisms of Metabolic Enzyme Related to Polycyclic Aromatic Hydrocarbons Risk of Preterm Birth].

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

Relationship between metabolic enzyme polymorphism and colorectal cancer.

Prelininary research on candidate genes SNP about gestational diabetes mellitus.

[Research on Exposure to Polycyclic Aromatic Hydrocarbons During Pregnancy and Risk of Preterm Birth].

Effect Modification of CPY2E1 and GSTZ1 Genetic Polymorphisms on Associations Between Prenatal Disinfection By-Products Exposure and Birth Outcomes.

Progress in research of cytochrome P450 3A4 gene polymorphism

Polymorphisms in gene UGT1A1 modify the association of prenatal exposure to polycyclic aromatic hydrocarbons with congenital heart diseases risk

[Polycyclic Aromatic Hydrocarbons Exposure and Birth Defects].

Urinary Biomarker of Prenatal Exposure to Disinfection Byproducts, Maternal Genetic Polymorphisms in CYP2E1 and GSTZ1, and Birth Outcomes.

Polycyclic aromatic hydrocarbon and its adducts in peripheral blood: Gene and environment interaction among Chinese population

Risk of congenital heart diseases associated with NAT2 genetic polymorphisms and maternal polycyclic aromatic hydrocarbons exposure

Low Organic Solvent Exposure and Combined Maternal-Infant Gene Polymorphisms Affect Gestational Age.

[Association of Cytochrome P450 Gene MSP1 Polymorphism and Risk of Preterm].

Are Polymorphisms in Metabolism Protective or a Risk for Reduced White Blood Cell Counts in a Chinese Population with Low Occupational Benzene Exposures?

Adverse impact of phthalate and polycyclic aromatic hydrocarbon mixtures on birth outcomes: A metabolome Exposome-Wide association study

Effects of Prenatal Polycyclic Aromatic Hydrocarbon Exposure on Neonatal Outcomes—MLR and BKMR Models

Prenatal Urinary Polycyclic Aromatic Hydrocarbon Metabolites, Global DNA Methylation in Cord Blood, and Birth Outcomes: A Cohort Study in China.

[Association of CYP2E1 of PON2311 Polymorphisms in Neonates with Preterm].

[Associations of Rsa I Polymorphism at the 5' Flanking Region of CYP2E1 and PON2 148 Polymorphism in Neonates with Preterm Delivery].

Maternal Genetic Polymorphisms of Phase Ii Metabolic Enzymes and the Risk of Fetal Neural Tube Defects